2022 Speakers
Browse the 2022 speakers below, or click here to take a look at the 2023 Agenda.
Elsa Abranches
Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca
John Campbell
Director, Tissues Cells & Advanced Therapeutics • Scottish National Blood Transfusion Service
Lee Aiyegbusi
Deputy Director Centre for Patient-Reported Outcomes Research (CPROR) • University of Birmingham CPROR
Mark Trusheim
Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)
Ryan Hicks
Senior Director – Head of Bioscience Cell Therapy, BioPharmaceuticals, R&D Cell Therpay • AstraZeneca
Stuart Curbishley
Head of Business and Project Development – Advanced Therapies • University of Birmingham
Takis Athanasopoulos
Director, Head of Patient Operations, Product Development & Supply Cell & Gene Therapy • GSK
Uta Griesenbach
Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London